vTv Therapeutics (VTVT) Asset Utilization Ratio (2015 - 2026)
vTv Therapeutics' (VTVT) quarterly Asset Utilization Ratio came in at 0.39 in Q1 2026, up 80618.2% year-on-year from N/an in Q1 2025, and up 144520.54% quarter-over-quarter from 0.0 in Q3 2025.
vTv Therapeutics (VTVT) Asset Utilization Ratio (2015 - 2026) Analysis & Trends
vTv Therapeutics has disclosed Asset Utilization Ratio across 12 years of filings, most recently posting 0.39 for Q1 2026.
- Asset Utilization Ratio for Q1 2026 came in at 0.39, up 80618.2% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.39 (up 80618.2% YoY), and the FY2024 annual result was 0.04, changed N/A from the prior year.
- Asset Utilization Ratio came in at 0.39 for Q1 2026 at vTv Therapeutics, up from 0.0 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 0.39 in Q1 2026 to a low of 0.0 in Q3 2025.
- The 5-year median for Asset Utilization Ratio is 0.02 (2024), against an average of 0.07.
- Across the five-year window, Asset Utilization Ratio slumped 99.8% in 2023 and jumped 80618.2% in 2026, its largest moves.
- vTv Therapeutics' Asset Utilization Ratio stood at 0.06 in 2022, then plunged by 99.18% to 0.0 in 2023, then soared by 5083.04% to 0.02 in 2024, then sank by 98.92% to 0.0 in 2025, then soared by 144520.54% to 0.39 in 2026.
- The last three Asset Utilization Ratio figures came in at 0.39 (Q1 2026), 0.0 (Q3 2025), and 0.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 0.55 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.60 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 1,422.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 0.47 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | vTv Therapeutics | 426.76 Mn | 426.76 Mn | - | 0.39 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.39 |
| Sep 30, 2025 | 0.00 |
| Jun 30, 2025 | 0.00 |
| Mar 31, 2025 | 0.00 |
| Dec 31, 2024 | 0.02 |
| Sep 30, 2024 | 0.02 |
| Jun 30, 2024 | 0.02 |
| Mar 31, 2024 | 0.03 |
| Sep 30, 2023 | 0.00 |
| Jun 30, 2023 | 0.00 |
| Mar 31, 2023 | 0.00 |
| Dec 31, 2022 | 0.06 |
| Sep 30, 2022 | 0.06 |
| Jun 30, 2022 | 0.18 |
| Mar 31, 2022 | 0.22 |
| Dec 31, 2021 | 0.14 |
| Sep 30, 2021 | 0.39 |
| Jun 30, 2021 | 0.39 |
| Mar 31, 2021 | 0.47 |
| Dec 31, 2020 | 0.59 |